title: Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
authors: Institute of Clinical Research, University Montpellier 1, Montpellier, France louis.monnier@inserm.fr.
authors: Louis
authors: L
authors: Monnier
authors: Institute of Clinical Research, University Montpellier 1, Montpellier, France.
authors: Claude
authors: C
authors: Colette
authors: Department of Endocrinology, Hospital Pitié Salpétrière, Paris, France.
authors: Sylvie
authors: S
authors: Dejager
authors: Diabetes Research Group, Swansea University, Swansea, U.K.
authors: David
authors: D
authors: Owens
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002940:Circadian Rhythm; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004032:Diet; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents